missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18514016

Complement Component C3aR Antibody (620613) [DyLight 755], Novus Biologicals™

Rat Monoclonal Antibody

Brand:  Novus Biologicals FAB10417Z

4480.00 SEK valid until 2025-03-28
Use promo code "25306" to get your promotional price.

Product Code. 18514016

  • 5600.00 SEK / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

Complement Component C3aR Monoclonal antibody specifically detects Complement Component C3aR in Mouse samples. It is validated for Flow Cytometry, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Complement Component C3aR
Monoclonal
DyLight 755
50mM Sodium Borate
Rat
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Mouse
Purified
Flow Cytometry, CyTOF
620613
Flow Cytometry, CyTOF-ready
AZ3B, AZ3BC3a anaphylatoxin chemotactic receptor, C3a-R, C3AR, C3AR1, C3ARcomplement component 3 receptor 1, C3R1, complement component 3a receptor 1, Complement Component C3a R, Complement Component C3aR, HNFAG09
Chinese hamster ovary cell line CHO-derived transfected with mouse C3aR, Accession # O09047
0.1 mL
GPCR
719
Store at 4°C in the dark.
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.